|
Katherine Morley PhD Candidate and Research Assistant Kate started studying at the University of Queensland in 1997. She dabbled briefly in Film and Television, Immunology, Latin, and Parasitology before graduating with a Bachelor of Arts in History and a Bachelor of Science in Genetics in 2000. During this time she also worked at the Queensland Institute of Medical Research, researching behavioural genetics and gene mapping techniques for complex traits. She went on to complete her Honours degree through the Zoology and Entomology department at UQ in 2001. Her Honours research was undertaken at the Genetic Epidemiology Laboratory at QIMR and examined genetic influences on female fertility. Kate joined OPPE as a full-time research assistant in January 2002, but the undeniable attraction of student life led her to enrol in a PhD in 2004, with Prof Hall and Dr Treloar as supervisors. Her project will examine genetic influences on smoking cessation, and is a collaborative effort involving OPPE and the Genetic Epidemiology Laboratory at QIMR, as well as the Department of Psychiatry at Washington University, St Louis USA. To find out more about this project click here.
Kate is primarily
interested in genetic research on the aetiology of stigmatised behaviours,
and pharmacogenetics and pharmacogenomics. However, she also has strong
interests in the economic and policy issues relating to genetic
technologies; science communication and public understanding of science;
and the
impact
of
biotechnology on reproduction. Contact Details Phone: 3346 2152
Publications Hall, W., Carter, L. & Morley K.I. (2004) Neuroscience research on the addictions: A prospectus for future ethical and policy analysis. Addictive Behaviors, 29 (7): 1481-95. Morley, K.I., Hall, W.D. & Carter, L. (2004) Genetic screening for susceptibility to depression: can we and should we? Australian and New Zealand Journal of Psychiatry, 38(1-2): 73-80. Yeh, M., Morley, K.I. & Hall, W.D. (2004) The policy and ethical implications of genetic research on Attention Deficit Hyperactivity Disorder. Australian and New Zealand Journal of Psychiatry, 38(1-2): 10-19. Morley, K.I. & Hall, W.D. (2004) Using pharmacogenetics and pharmacogenomics in the treatment of psychiatric disorders: some ethical and economic considerations. Journal of Molecular Medicine, 82: 21-30. Hall, W., Morley,
K. I. & Carter, L. (2003) Genetics and depression: ethical and policy
implications. In Breaking the Code: 2002 Symposium, Occasional Paper No.
5 (Melbourne: Centre for Law and Genetics). Montgomery, G.W., Duffy, D., Morley, K.I., Zhao, Z.Z., Marsh, A.J., Boomsma, D.I. & Martin, N.G. (2003) Variation in dizygotic twinning is not associated with haplotypes at methylenetetrahydrofolate reductase. Human Reproduction, 18(11): 2460-2464. Hall, W., Carter, L. & Morley, K.I. (2003) Addiction, ethics and scientific freedom. Addiction, 98(7): 873-874. Hall, W., Carter, L. & Morley, K.I. (2003) Addiction, neuroscience and ethics. Addiction, 98(7): 867-870. Morley, K.I., Carter, L. & Hall, W. (2003) Regulation of embryonic stem cell research and therapeutic cloning: The Australian debate. Plaintiff, 55: 20-23. Hall, W., Carter, L. & Morley, K.I. (2002) Ethical implications of advances in neuroscience research on the addictions. National Drug and Alcohol Research Centre Technical Report No.143, Sydney: National Drug and Alcohol Research Centre. Morley, K.I. and Montgomery, G.W. (2001) The genetics of cognitive processes: Candidate genes in humans and animals. Behavior Genetics, 31(6): 511-531.
|
Contact webmaster: oppe@uq.edu.au
|